VRDN Earnings

Quarterly EPS
$-0.88
Q3 2024
$-0.80
Q4 2024
$-0.87
Q1 2025
$-1.00
Q2 2025
$-0.34
Q3 2025
$-1.07
Q4 2025
$-0.90
Q1 2026
$-1.05
Q2 2026
Latest Revenue284.0K
Latest Net Income-127119000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.05284.0K-127119000+278.7%-5.0%
Q1 2026-$0.90141.0K-104901000+95.8%-3.4%
Q4 2025-$1.07132.0K-120355000+83.3%-33.8%
Q3 2025-$0.3470.6M-34599000+81,958.1%+61.4%
Q2 2025-$1.0075.0K-100735000+4.2%-29.9%
Q1 2025-$0.8772.0K-86912000+0.0%-47.5%
Q4 2024-$0.8072.0K-79725000+0.0%-900.0%
Q3 2024-$0.8886.0K-76689000+19.4%+19.3%
Q2 2024-$0.7772.0K-64993000
Q1 2024-$0.5972.0K-48542000
Q4 2023-$0.0872.0K-66860000
Q3 2023-$1.0972.0K-47660000
Viridian Therapeutics (VRDN) — Earnings